A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphoma

Haematologica. 2023 Sep 14. doi: 10.3324/haematol.2022.282246. Online ahead of print.ABSTRACTNot available.PMID:37706336 | DOI:10.3324/haematol.2022.282246

Source: Haematologica - September 14, 2023 Category: Hematology Authors: Todd A Fehniger Marcus P Watkins Nkiruka Ezenwajiaku Fei Wan David D Hurd Amanda F Cashen Kristie A Blum Andre Goy Timothy S Fenske Nina D Wagner-Johnston Kenneth Carson Marilyn J Siegel David Russler-Germain Stephanie E Schneider Neha Mehta-Shah Brad Kah Source Type: research